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Introduction.Several studiesshowed anassociationofoverweight andobesitywithcalciumoxalatestonedisease(CaOx).However,
there are no suﬃcient data on the inﬂuence of body weight on the course of the disease and the recurrence rate. Patients and
Methods. N = 100 consecutive stone formers with pure CaOx were studied. Diﬀerent parameters were investigated. According to
the BMI, patients were divided into three groups: (1) BMI ≤ 25; (2) BMI 25.1–30; (3) BMI > 30. Results. N = 32 patients showed
aB M I≤ 25, n = 42 patients showed a BMI of 25.1–30 and n = 26 patients showed a BMI ≥ 30. The groups diﬀered signiﬁcantly
concerning BMI (by deﬁnition), urine pH, and urine citrate. The recurrence rate was not signiﬁcantly diﬀerent. Discussion.O u r
study demonstrated that body weight negatively inﬂuences single risk factors in CaOx, but obesity is not a predictor for the risk of
recurrence in CaOx.
1.Introduction
Several studies showed an association of overweight and
obesity with calcium oxalate stone disease (CaOx) [1–3].
There was a correlation between body weight and promoters
of CaOx. In general stone disease is often associated with
diabetes [4–6]. For example, Maalouf et al. have shown in
2004 that there’s an reciprocal correlation between urinary
pH and overweight [7]. Other metabolic risk factors are
correlated with body weight: urinary pH, uric acid, calcium,
citrate, and oxalic acid [8–10]. So far, however, there are no
suﬃcient data on the inﬂuence of body weight on the course
of the disease and the recurrence rate of CaOx.
2. Patientsand Methods
N = 100 consecutive stone formers with pure CaOx treated
in the Department of Urology and Paediatric Urology at
the Klinikum Coburg, Germany, were studied. Stone anal-
ysis was performed by polarization microscopy and X-ray
diﬀraction. A detailed history including the number of stone
episodes occurring in the past was recorded.
The BMI was calculated after determining body weight
and height. Arterial blood pressure (RR) was measured
according to the recommendations of the World Hyperten-
sion League sitting after 5 minutes at rest. The following
parameters were determined in all these patients: Urine
pH proﬁles on three consecutive days at morning (fasting),
noon (postprandial) and evening (postprandial). For urine
pH measurements, dipsticks were used which allow pH
measuringin0.1steps(MadausGmbH,Cologne,Germany).
The mean urinary pH was calculated in every patient.
Blood was drawn to measure creatinine (Jaﬀ´ er e a c -
tion, Dade Behring Marburg, Germany), potassium (atomic
absorption), calcium (indirect ion sensitive electrode), glu-
cose (postprandially; hexokinase-glucose-6-phosohate dehy-
drogenase method, Flex Siemens Healthcare Diagnostics
Newark, DE, USA), and uric acid (modiﬁed uricase method,
Dade Behring Marburg, Germany). A 24h-urine specimen
was collected to determine the excretion of citrate (citrate
lyase method, Boehringer Mannheim, Germany), creatinine
(Jaﬀ´ e reaction, Dade Behring Marburg, Germany), calcium
(indirect ion sensitive electrode), uric acid (modiﬁed uricase
method, Dade Behring Marburg, Germany), ammonia2 Advances in Urology
(modiﬁed glutamate dehydrogenase method using NADPH,
test kit Ammonia Flex, Dade Int., Newark, DE, USA), and
urea (urease-glutamate dehydrogenase, Dade Behring Mar-
burg, Germany) as a marker for protein intake.
According to the BMI, patients were separated into three
groups: (1) BMI ≤ 25; (2) BMI 25.1–30; (3) BMI > 30.
In group 1 there were n = 23 men and n = 10 women in
the age of 21–85 years, in group 2 n = 27 men and n = 14
women in the age of 23–78 years, and in group 3 n = 20 men
and n = 6 women in the age of 27–78 years.
For statistic evaluation, the Kruskal-Wallis test was used.
It analyses the statistical signiﬁcance between three groups
(level of signiﬁcance P<0.05). For box blot graphs, we used
the program Prism 3 (GraphPad Software, San Diego, CA,
USA). The other ﬁgure was made with the use of microsoft
excel. Calculations were performed on a personal computer.
3. Results
The groups diﬀered signiﬁcantly concerning BMI (by def-
inition), urine pH, and urine citrate. With regard to the dis-
tribution between the sexes the group diﬀered not signiﬁ-
cantly.
N = 32 patients (32%) showed a BMI ≤ 25 (group 1)
(standard deviation (std) 1.67), n = 42 patients (42%)
showed a BMI of 25.1–30 (group 2) (std 1.308) and n = 26
patients (26%) showed a BMI ≥ 30 (group 3) (std 3.795).
Compared with Figure 1.
IfyoulookaturinarypHyoucanseeahigherurinarypH
in group 1 with lower BMI than in groups with higher BMI.
Group 1 had a median of urine pH of 6.20 (5.6–7.2; std
0.3931), group 2 a median of 6.06 (5.6–6.8; std 0.2879), and
group 3 a median of 5.95 (5.6–6.3; std 0.1873). Compared
with Figure 2.
Urine citrate excretions also diﬀered signiﬁcantly.
G r o u p1h a dam e d i a no fu r i n ec i t r a t eo f1 . 4 1m m o l / d
(0.1–3.9; std 0.9319), group 2 a median of 2.32mmol/d (0.4–
8.6; std 1.622), and group 3 a median of 1.92mmol/d (0.1–
4.0; std 1.096). The highest urine citrate with 8.6mmol/d
could be found in group 2 with a BMI of 25.1–30. Compared
with Figure 3.
All the other parameters showed no signiﬁcant diﬀer-
ences. Especially the recurrence rates were not signiﬁcantly
diﬀerent. There was even a tendency towards a decreasing
number of stone episodes with increasing body weight.
Group 1 had a median of 1.183 stone episodes (1–3; std
0.7803), group 2 a median of 1.683 (1–5; std. 1.083), and
group 3 a median of 1.423 stone episodes (1–3; std 0.5778).
However,thenumbersofstoneepisodeswasnotsigniﬁcantly
diﬀerent. Compared with Figure 4.
4. Discussion
Severalstudiesshowedanassociationofoverweightandobe-
sity with calcium oxalate stone disease (CaOx) [1–3, 11, 16].
West et al. described that factors of the metabolic syn-
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Figure 2: Urine pH in all three groups (P = 0.0476, statistically
signiﬁcant).
kidney stones [11]. Many of these studies did not diﬀer-
entiate between diﬀerent stone types, but only looked at
a potential association between BMI and the fact whether
patients reported a kidney stone in the past. They did not
investigate the course of the disease and the recurrence rate,
respectively.
There was a correlation between body weight and pro-
moters of CaOx [1–3]. However, when adjusted for multiple
covariates, there was no inﬂuence of BMI on these risk
factorsandthecalciumoxalatesupersaturation[12].Positive
associations between BMI and urinary calcium excretion
are due to diﬀerences in dietary habits (animal protein and
sodium intake) [12].
In general, stone disease is often associated with diabetes,
a part of the metabolic syndrome [4–6]. This is in particular
true for uric acid lithiasis. If you look at this you can see
that reducing insulin resistance by for example, reducing
body weight may increase urinary pH and therefore it
might be helpful for preventing stone forming [11, 13]. In
our population there were only n = 7 people with dia-
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Figure 4: Stone episodes of group 1, 2, and 3 (not signiﬁcantly
diﬀerent).
decreasing insulin resistance only will help to increase uri-
nary pH.
We investigated only CaOx stone formers. It is important
to separate between diﬀerent stone compositions. As shown
b yT a y l o ra n dC u r h a n[ 12], BMI had diﬀerently inﬂuenced
stoneriskfactorsinCaOxcomparedwithuricacidstonefor-
mers. In our population, people with higher BMI (included
people with diabetes) and lower urinary pH had a decreased
recurrence rate. Therefore, it is not possible to predict the
probability of forming stones by measuring urinary pH [14].
In our study, most people were overweight or obese
(68%). In the general population there are only 49%
overweight or obese [15]. Compared to this, there were more
obese subjects (BMI ≥ 30) among our CaOx stone formers.
This is a higher number than in previous studies [1]. But
obviously, this had no impact on the recurrence rate.
Siener et al. [1] and also Taylor et al. [16] wrote that
peoplewithhigherBMIhadanincreasedriskofkidneystone
formation. Sarica et al. described in 2011 that a correct body
weight for example could prevent one from forming stones
[17, 22].
All these studies did not look at the recurrence rate
but only at a self-reported history of kidney stones. We in-
vestigated the inﬂuence of overweight and obesity not only
on fact of having a kidney stone in the past, but also on the
course of the disease. There was no inﬂuence of body weight
on the recurrence rate in our population. People with higher
BMI had a decreased recurrence rate. Therefore, obesity is
not a predictor for the risk of recurrence in CaOx.
This may be not surprising at second sight. Taylor and
Curhan [12] reported that there was no relation between
BMI and calcium oxalate supersaturation. They suggested
thatriskofcalciumoxalatestoneformationdoesnotincrease
with increasing body size. They suggested that greater
incidence of kidney stones in the obese may be due to an
increase in uric acid nephrolithiasis. This is in accordance
with our ﬁndings that the recurrence rate of calcium oxalate
stones does not increase with increasing BMI.
Abovethatitisveryquestionableifreducingbodyweight
may positively inﬂuence kidney stone forming disease.
Maybe eating habits may be more important than reducing
body weight.
In our population there were 30 women and 70 men. In
the study of Taylor it was written that women were more
inﬂuenced by obesity and stone forming than men. Maybe
this is correct because men were often in our population ﬁrst
stone formers in contrast to women, who had more than one
stoneinlife.Maybethehormonesareimportantforthat,too.
Most women were in (pre- or postmenopause).
But in accordance with previous reports body weight
negatively inﬂuences single risk factors in CaOx [1, 9, 10, 13,
17].
Risk factors for forming stones like for example urinary
citrateareoftenreviewedinstudies.Thereisalsowrittenthat
lower urinary citrate may lead to forming CaOx [18]. In our
studythishypothesiscouldbeconﬁrmed,too.Therewasalso
like in several studies before a decreased number of forming
stones with higher urinary citrate [19]. Therefore, citrate
excretionhastobeaprotectivefactoragainstformingstones.
Opposed to that, Sikora et al. wrote that in their population
most people with CaOx had normal urinary citrate [20]. So
only looking at urinary citrate you wouldn’t get a predictor
for forming stones.
Urolithiasis is a multifactorial disease [21]. Lifestyle and
eating habits have an eﬀect on lithogenic urinary risk factors
[22]. Maybe the composition of food has a higher inﬂuence
on forming stones than body weight. Therefore, a change in
food composition might be promising.
In conclusion, our study demonstrated that body weight
negatively inﬂuences single risk factors in CaOx, but obesity
is not a predictor for the risk of recurrence in CaOx.
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